10 minutes ago ... Brzica adds that although the change will not have an immediate effect on beneficiaries' out-of-pocket costs, “the inclusion of biosimilars in the Medicare formulary will ultimately lead to lower premiums for them.” The AARP Public Policy Institute found that the average annual cost for a biologic drug used on ...
No comments:
Post a Comment